About the Study
ACEMg is a safe nutraceutical regulated as a supplement, the product of medical research. This 24-week study is the first open-label, post-marketing study to further confirm ACEMg's benefits on hearing and explore its potential to relieve tinnitus symptoms in the general public. Participation is free.
Study Status: Enrollment in the study, listed on the NIH site ClinicalTrials.gov, is currently suspended, pending the conclusion of its first annual IRB review.
Study Partnership
The OTIS study is a collaboration between Keep Hearing Initiative and Soundbites Public Benefit Corporation. Keep Hearing is responsible for IRB compliance, data analysis, and public health reporting. Soundbites PBC donates the ACEMg test product and is responsible for data collection. Both partners are responsible for recruitment, enrollment, and data security.
Study Benefits
Potential Benefits to You
There is a good chance you may benefit from taking Soundbites, but there is no guarantee. If you already have hearing loss, it may stop getting worse, or your hearing may get better. If you have tinnitus, the sounds may get quieter. There is no cure for tinnitus because medical scientists don't yet fully understand what causes it.
Soundbites was not designed for tinnitus, but since its release in 2017, customers and audiologists have reported that daily use of Soundbites reduces tinnitus symptoms for some. The study tests the hypothesis that tinnitus sounds may get quieter because Soundbites is helping hearing cells stay healthier.
Potential Benefits to Others
Hearing loss is one of the most common chronic health problems of our time worldwide. Soundbites is the first clinically proven preventive care solution for hearing. This study may help more people know about and trust Soundbites to keep the hearing they have, and it may also help some people who suffer with tinnitus.
This study may help medical scientists learn more about what causes tinnitus. This study may also contribute to cognitive health because hearing loss in midlife is the #1 risk factor for dementia. Scientists agree that preserving hearing is the single best way to reduce dementia risk.
Stay Informed
Sign up to receive updates about the OTIS study and future enrollment opportunities.
Send an email to: bseifer@keephearing.org